STOCK TITAN

Medline officially launches Mpower™, a digital control tower designed to predict, respond and resolve supply chain risks

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Medline (Nasdaq: MDLN) launched Mpower on May 4, 2026: a cloud-based, AI-powered digital control tower for healthcare supply chains built with Microsoft. Early deployment with 10 U.S. health systems produced >50% efficiency gains in order substitution workflows and 1–2% higher unadjusted fill-rates. Mpower integrates Medline supply and demand data, includes an AI chat agent, leverages Microsoft Azure and Office 365, and will roll out in phases throughout 2026 with additional capabilities planned.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • >50% efficiency gain in order substitution workflows versus a 5–7 day baseline
  • Built with Microsoft and uses Azure and Office 365 for security and integration
  • Early adoption by 10 U.S. health systems informing product refinement

Negative

  • Phased rollout through 2026 delays full availability for some customers
  • Modest fill-rate lift of 1–2% may be limited for some large systems

News Market Reaction – MDLN

-1.25%
1 alert
-1.25% News Effect

On the day this news was published, MDLN declined 1.25%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Early adopter systems: 10 health systems Efficiency gain: more than 50% Baseline workflow time: 5–7 days +5 more
8 metrics
Early adopter systems 10 health systems Early release test group for Mpower platform
Efficiency gain more than 50% Improvement in order substitution workflows vs five- to seven-day baseline
Baseline workflow time 5–7 days Pre-Mpower order substitution workflow and decision-making baseline
Fill-rate improvement 1–2% Increase in unadjusted fill-rates with Mpower and AutoSub program
Net sales $28.4 Billion Full-year 2025 net sales, up 11.5% year over year
Net income $1.2 Billion Full-year 2025, down 3.6% year over year
Adjusted EBITDA $3.5 Billion Full-year 2025, up 3.2% year over year
Free cash flow $1.3 Billion Full-year 2025 free cash flow

Market Reality Check

Price: $39.52 Vol: Volume 2,837,795 vs 20-da...
low vol
$39.52 Last Close
Volume Volume 2,837,795 vs 20-day average 5,011,515 (relative volume 0.57), indicating lighter-than-normal trading ahead of this launch. low
Technical Price $44.75 is trading slightly above 200-day MA at $44.30, with shares 12.04% below the 52-week high and 28.26% above the 52-week low.

Historical Context

5 past events · Latest: Apr 16 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Apr 16 AI robotics partnership Positive -2.1% Announced Symbotic AI-enabled warehouse automation pilot for 2027 fulfillment upgrade.
Apr 08 Earnings date notice Neutral +2.8% Set date and details for Q1 2026 earnings release and investor call.
Apr 06 Automation launch Positive -0.9% Launched Pick Pack Pro robotic fulfillment at NY center with planned network rollout.
Apr 01 Industry awards Positive -1.1% Received HIRC awards recognizing supply-chain resiliency and transparency efforts.
Mar 11 DC expansion Positive -1.1% Broke ground on 1.2M sq. ft Texas distribution center with advanced automation.
Pattern Detected

Recent operational and technology-focused announcements tended to see negative next-day price reactions, suggesting investors have not consistently rewarded these strategic supply-chain upgrades in the short term.

Recent Company History

Over the past few months, Medline has highlighted expansion and modernization of its supply-chain infrastructure, including a new 1.2 million sq. ft. Texas distribution center and robotics-driven fulfillment systems. Awards for resiliency and supplier partnership reinforced its positioning with providers. Despite positive operational tone, several of these news items were followed by modest negative price reactions. Today’s launch of the AI-enabled Mpower™ control tower continues this theme of technology-driven supply-chain innovation within a similar strategic trajectory.

Market Pulse Summary

This announcement highlights Medline’s push to digitize its healthcare supply chain via the AI-enabl...
Analysis

This announcement highlights Medline’s push to digitize its healthcare supply chain via the AI-enabled Mpower™ control tower, citing more than 50% efficiency gains and a 1–2% fill-rate lift in early adopters. It follows recent investments in robotics and new distribution capacity, suggesting a broader logistics modernization strategy. Investors may track adoption beyond the initial 10 health systems, realized workflow improvements at scale, and how these tools influence key financial metrics like net sales growth and cash generation over time.

AI-generated analysis. Not financial advice.

First wave of Medline customers begin leveraging Mpower to strengthen supply chain resiliency

NORTHFIELD, Ill., May 4, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) announced that its cloud-based, AI-powered supply chain technology called Mpower™ is now available to help healthcare providers anticipate and respond to potential disruptions before they impact patient care. Built in collaboration with Microsoft and developed with direct input from health systems across the country, Mpower represents a significant step forward in modernizing healthcare supply chain decision-making.

The solution is a digital control tower that predicts future risks, offers real-time solutions with proactive optimizations and automates workflows – bringing Medline's customer supply and demand data, predictive analytics and workflow automation together into an intuitive and actionable dashboard. With real-time insights, Mpower helps providers proactively identify at-risk items earlier and streamline their product substitutions and approval workflows, thereby reducing the daily operational burden for supply chain and clinical teams.

Mpower also includes an integrated AI chat agent that enables users to ask questions, explore product alternatives and streamline clinical approvals directly within the platform. The system draws on Medline's extensive, end‑to‑end supply chain data as both a manufacturer and distributor to deliver enhanced real-time visibility into inventory positions, demand forecasts and potential vulnerabilities across supply networks. Leveraging the Microsoft Office 365 integration users are familiar with and the advanced data security of Microsoft Azure, Mpower is designed to be straightforward and secure to integrate, with minimal training required and the ability to deploy quickly.

"Mpower reflects how we approach technology at Medline – building practical solutions in close collaboration with partners and customers," said Marshall Lancaster, Medline chief information officer. "Working with Microsoft, we focused on creating a cloud‑based platform that can be deployed efficiently, integrates seamlessly into existing environments and delivers meaningful value from day one."

Following an early release with 10 well-known U.S. health systems, all of which worked closely with Medline to test, refine and help shape the platform ahead of broader availability, initial data shows a more than 50% efficiency gain in order substitution workflows and decision making compared to a five- to seven-day baseline without Mpower. Health systems using Mpower along with integrating into Medline's pre-approved AutoSub program saw a 1-2% increase in unadjusted fill-rates.

"We're appreciative for the years of collaboration with providers who told us they needed better visibility, simpler workflows and smarter tools to help manage an increasingly complex global supply chain," said Marc Phillips, Medline senior vice president, supply chain solutions. "By combining Medline's supply chain expertise with Microsoft's cloud and AI capabilities, we expect the technology to play a central role in helping healthcare providers navigate ongoing volatility while building more resilient, data-driven supply chains for the future."

Mpower is rolling out to Medline customers in phases throughout 2026, with additional capabilities planned as the platform evolves.

Learn more about how Medline can support customers in optimizing their supply chains at go.medline.com/mpower.

About Medline
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Ill., the company employs more than 45,000 people worldwide and operates in more than 100 countries. To learn more about how Medline makes healthcare run better, visit www.medline.com.

Unless otherwise indicated, all figures are as of Dec. 31, 2025. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/medline-officially-launches-mpower-a-digital-control-tower-designed-to-predict-respond-and-resolve-supply-chain-risks-302761607.html

SOURCE Medline

FAQ

What is Medline's Mpower and when was it launched (MDLN)?

Mpower is a cloud-based AI supply chain control tower launched May 4, 2026. According to the company, it combines Medline supply and demand data, predictive analytics, workflow automation and an AI chat agent for real-time inventory and substitution decisions.

How much efficiency improvement did Mpower show in early MDLN tests?

Early users saw more than a 50% efficiency gain in order substitution workflows versus a five- to seven-day baseline. According to the company, this metric came from 10 health systems that tested and refined the platform.

What integration and security does Mpower (MDLN) use for deployment?

Mpower integrates with Microsoft Office 365 and runs on Microsoft Azure for advanced data security. According to the company, this design aims for straightforward integration, minimal training, and faster deployment into existing IT environments.

What customer impact did Medline report for AutoSub users with Mpower (MDLN)?

Health systems using Mpower plus Medline's pre-approved AutoSub program saw a 1–2% increase in unadjusted fill-rates. According to the company, that improvement reflects combined platform and AutoSub integration during early trials.

When will Mpower be broadly available to Medline customers (MDLN)?

Mpower is rolling out in phases throughout 2026 with additional capabilities planned. According to the company, phased deployment follows early-release testing with 10 health systems to refine features before wider availability.